GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Outlook Therapeutics Inc (XTER:41O) » Definitions » Allowance For Loans And Lease Losses

Outlook Therapeutics (XTER:41O) Allowance For Loans And Lease Losses


View and export this data going back to 2019. Start your Free Trial

What is Outlook Therapeutics Allowance For Loans And Lease Losses?

Allowance For Loans And Lease Losses only applies to banks.


Outlook Therapeutics Business Description

Industry
Traded in Other Exchanges
Address
485 Route 1 South Building F, Suite 320, Iselin, NJ, USA, 08852
Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications.